PRP Joint Therapy Solutions in Honolulu, HI

How Honolulu is not Florida First Coast

Adult arthritis here is 21.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 13.2% of adults in Honolulu have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Together those PLACES numbers are why a city of 250k–500k still needs separate PRP and CTP protocols. prp joint therapy inventory is national; utilization is JE-local.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 21.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 5.2% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Hawaii.
• In a city of 250k–500k, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Honolulu street address.
• First Coast (Florida) is the only single-state MAC; every other state shares a contractor with neighbors. Hawaii is JE — copy-pasting a Florida LCD packet here is a denial pattern we still see.

What CDC PLACES and JE each actually tell you

JE reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Honolulu is 13.2% or not. PLACES is planning data. The LCD is the claim.

Before the first prp joint therapy shipment